Business
Directorate Change & Appointment
Directorate Change & Appointment.
About this update from Hemogenyx Pharmaceuticals Plc
[{"type":"text","content":"\n \nRNS Number : 2678G Hemogenyx Pharmaceuticals PLC 05 November 2018 \n\nHemogenyx Pharmaceuticals plc\n(\"Hemogenyx\" or the \"Company\")\n \nDirectorate Change and Appointment of Financial Controller and Company Secretary\n \nHemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments designed to transform bone marrow transplantation for the treatment of blood diseases, announces that Andrew Wright has been appointed as Financial Controller & Company Secretary, a non-Board position, and that Lawrence Pemble, Chief Operating Officer, will step down from the Board, both with immediate effect.\n \nAndrew began his career in audit at PricewaterhouseCoopers and has an MBA in Finance and Strategy from the UCLA Anderson School of Management in Los Angeles, USA. He serves as Director of Corporate Development and Technology for Thomas Murray, a post-trade capital markets data and advisory firm. Andrew is also an Executive Director of Trayned Insight Ltd, a data science company serving the healthcare and pharmaceutical industries.\n \nDr. Vladislav Sandler, CEO of Hemogenyx, commented:\n\"I am delighted to welcome Andrew to the team and look forward to his support as we continue to advance the development of our novel therapeutic products for patients with blood and severe autoimmune diseases. I would also like to extend my thanks to Lawrence for his contribution to the Board and we wish him well in his next ventures.\"\n \n \nEnquiries:\n \n\n\n\nHemogenyx Pharmaceuticals Limited\n\n\nwww.hemogenyx.com\n\n\n\n\nDr Vladislav Sandler, Chief Executive Officer & Co-Founder\n\n\nVia Walbrook PR\n\n\n\n\nSir Marc Feldmann, Executive Chairman\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNorthland Capital Partners Limited\n\n\nTel: +44 (0)20 3861 6625\n\n\n\n\nMatthew Johnson, Vadim Alexandre, Dugald J Carlean\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPeterhouse Corporate Finance Limited\n\n\nTel: +44 (0)20 7469 0930\n\n\n\n\nLucy Williams, Duncan Vasey\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR (UK Media & Investor Relations)\n\n\nTel: +44 (0)20 7933 8780 or [email protected]\n\n\n\n\nPaul McManus\n\n\nMob: +44 (0)7980 541 893\n\n\n\n\n\n\n\n\n\n\n\n\nUS Media enquiries\n\n\n\n\n\n\n\nLowell Goodman\n\n\nTel: +1 (323) 646-3249 or lowell@corbomitecomm...